Nicotinic acid: recent developments.

Curr Opin Cardiol

Atherosclerosis Research Center, Department of Veterans Affairs Healthcare System, Long Beach, California, USA.

Published: July 2008

Purpose Of Review: To review the recent progress in niacin research that is made in two major areas: new preparations to decrease flushing and niacin's mechanism of action.

Recent Findings: Flushing, an adverse effect of niacin, results from GPR109A-mediated production of prostaglandin D2 and E2 in Langerhans' cells which act on DP1 and EP2/4 receptors in dermal capillaries causing their vasodilatation. DP1 receptor antagonist (laropiprant) attenuates the niacin flush in animals and humans. A reformulated preparation of extended-release niacin lowers flushing compared with the extended-release niacin (Niaspan, Abbott Laboratories, Chicago, Illinois, USA). Aspirin pretreatment attenuates flushing from Niaspan. Recent data on niacin's mechanism of action indicate that it directly inhibits hepatic diacylglycerolacyl transferase 2 resulting in an inhibition of triglyceride synthesis and decreased apolipoprotein B-containing lipoproteins; niacin, by inhibiting the surface expression of hepatic ATP synthase beta chain, decreases the hepatic holoparticle high-density lipoprotein catabolism and raises high-density lipoprotein levels; and niacin increases redox potential in arterial endothelial cells resulting in the inhibition of redox-sensitive genes.

Summary: Recent developments suggest that the niacin receptor GPR109A is involved in flushing, but it does not explain multiple actions of niacin. Actions of niacin on diacylglycerolacyl transferase 2, ATP synthase beta chain, and redox state may explain the multiple actions of niacin.

Download full-text PDF

Source
http://dx.doi.org/10.1097/HCO.0b013e3283021c82DOI Listing

Publication Analysis

Top Keywords

actions niacin
12
niacin
11
niacin's mechanism
8
extended-release niacin
8
diacylglycerolacyl transferase
8
atp synthase
8
synthase beta
8
beta chain
8
high-density lipoprotein
8
explain multiple
8

Similar Publications

Combined action of dietary-based approaches and therapeutic agents on cholesterol metabolism and main related diseases.

Clin Nutr ESPEN

January 2025

Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253, Bragança, Portugal; Laboratório Associado para a Sustentabilidade e Tecnologia em Regiões de Montanha (SusTEC), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253, Bragança, Portugal. Electronic address:

Background: Dyslipidaemia is among the major causes of severe diseases and, despite being well-established, the hypocholesterolaemic therapies still face significant concerns about potential side effects (such as myopathy, myalgia, liver injury digestive problems, or mental fuzziness in some people taking statins), interaction with other drugs or specific foods. Accordingly, this review describes the latest developments in the most effective therapies to control and regulate dyslipidaemia.

Scope And Approach: Herein, the metabolic dynamics of cholesterol and their integration with the current therapies: statins, bile acid sequestrants, fibrates, niacin, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, reconstituted high-density lipoprotein (rHDL), or anti-inflammatory and immune-modulating therapies), were compared focusing their effectiveness, patients' adhesion and typical side-effects.

View Article and Find Full Text PDF

Background: Highly polar herbicides, such as imidazolinones, are used for weed control to increase agricultural productivity and crop quality. However, their misapplication can lead to residues in ready-to-eat food with a potential health risk for consumers. Hence, the fast determination of these herbicides is necessary for timely action.

View Article and Find Full Text PDF

Unraveling the benefits of DSM 29784 poultry probiotic through its secreted metabolites: an approach.

Microbiol Spectr

November 2024

European Laboratory of Innovation Science & Expertise (ELISE). Adisseo France S.A.S., Saint Fons, France.

Article Synopsis
  • The probiotic 29784 (Bs29784) supports chicken intestinal health by producing metabolites like hypoxanthine, niacin, and pantothenate, enhancing resilience and performance through immune response, barrier function, and microbiota modulation.
  • Experimental models showed that Bs29784 vegetative cells significantly reduced inflammation and improved intestinal integrity better than spores, while individual metabolites had distinct positive effects on inflammation and cell growth.
  • Fermentation studies revealed that different metabolites influenced the microbiota and fermentation profiles, with specific compounds like PTH and HPX enhancing epithelial resilience and overall intestinal health.
View Article and Find Full Text PDF

This study aims to observe the effects of the traditional Chinese medicine prescription Dahuang Zhechong Pills(DHZCP on renal aging and explore its potential multi-target effects. Rats were assigned into the normal, model, DHZCP, and vitamin E(VE)groups. Firstly, the rat model of D-galactose(D-gal)-induced renal aging was established.

View Article and Find Full Text PDF

Depression is a major global health concern expected to worsen by 2030. In 2019, 28 million individuals were affected by depressive disorders. Dietary and supplemental vitamins show overall favorable preventative and therapeutic effects on depression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!